Overexpression of S100A9 can exacerbate lung injury and inflammation in patients with allergic asthma, whereas inhibition of S100A8 and S100A9 can stabilize macrophage polarization and inhibit glycolysis to improve allergic asthma (Ji et al., 2024). Here, S100A9 is linked to allergic asthma.